U.S. Markets closed

Investors Pressure Firms on Opioid Crisis

Jackie Cook (jackie.cook@morningstar.com)

As the opioid crisis continues to rage in the United States, publicly traded companies that manufacture, market, or sell the prescription drugs at the center of the epidemic are facing shareholder resolutions for governance reforms and improved disclosure of risks around their involvement in the making or sale of the drugs. In the process, this effort is turning the spotlight to how major fund companies and other big investors are casting their proxy votes in 2019. Starting this week and continuing over the next month, shareholders of  Johnson & Johnson JNJ [1],  Mallinckrodt  MNK , and  CVS Health  CVS will be voting on opioid-related resolutions.